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Abstract The silver nanoparticles were synthesized by
chemical reduction method and the nanoparticles were
characterized using ultraviolet–visible (UV–Vis) absorp-
tion spectroscopy and X-ray diffraction (XRD) studies. The
synthesized silver nanoparticles were investigated to eval-
uate the antibacterial activity against urinary tract infec-
tious (UTIs) bacterial pathogens. Thirty-two bacteria were
isolated from mid urine samples of 25 male and 25 female
patients from Thondi, Ramanathapuram District, Tamil
Nadu, India and identified by conventional methods.
Escherichia coli was predominant (47%) followed by
Pseudomonas aeruginosa (22%), Klebsiella pneumoniae
(19%), Enterobacter sp. (6%), Proteus morganii (3%) and
Staphylococcus aureus (3%). The antibacterial activity
of silver nanoparticles was evaluated by disc diffusion
assay. P. aeruginosa showed maximum sensitivity (11 ±
0.58 mm) followed by Enterobacter sp. (8 ± 0.49 mm) at
a concentration of 20 lg disc-1 and the sensitivity was
highly comparable with the positive control kanamycin and
tetracycline. K. pneumoniae, E. coli, P. morganii and
S. aureus showed no sensitivity against all the tested con-
centrations of silver nanoparticles. The results provided
evidence that, the silver nanoparticles might indeed be the
potential sources to treat urinary tract infections caused by
P. aeruginosa and Enterobacter sp.
Keywords Antibacterial sensitivity  Disc diffusion
assay  Silver nanoparticles  UTI
Introduction
Patients with non-infectious diseases who have to stay in
hospital for long period such as heart disease, cancer and
other chronic diseases have high risk to get nosocomial
infections (Nichollas et al. 1975; Asefzadeh 2005; Saonu-
am et al. 2008). It has been reported that, 10% hospital
patients acquire this infection while staying in hospital
(Asefzadeh 2005). The common pathogenic bacteria
which include Escherichia coli, Klebsiella pneumoniae,
Haemophilus influenza, Streptococcus pneumoniae and
Proteus vulgaris are the major causative agents of noso-
comial infections (Saonuam et al. 2008; Nichollas et al.
1975). Generally, nosocomial infections develop in respi-
ratory tract (Nichollas et al. 1975) and urinary tract
(Saonuam et al. 2008). Treatment with available antibiotics
leads to resistance among pathogenic bacteria which leads
to greater threat.
In the recent years, silver nanoparticles have been of
great interest and widely investigated because of their
applications in many areas such as biotechnology (Gao and
Xu 2009), microelectronics (Feldheim and Keating 1998),
optics (Taton et al. 2000; Zhang et al. 2005) and biomed-
icine (Caruthers et al. 2007; Farokhzad and Langer 2006;
Sahoo et al. 2007; Kumar et al. 2005). It is well known that
silver is a very effective antibacterial agent and also pos-
sesses a strong activity against bacteria, fungi and viruses,
although the mechanism and the manner of action are still
not well known (Sharma et al. 2009). Several studies
reported that, the silver and silver nanoparticles may attach
to the surface of the cell membrane disturbing permeability
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and respiration functions of the cell (Kvitek et al. 2008). It
is also possible that silver and silver nanoparticles not only
interact with the surface of membrane, but can also pene-
trate inside the bacteria (Morones et al. 2005). Many
researchers also proposed that Ag? ions interact with the
thiol groups in bacteria proteins, affecting the replication of
DNA (Marini et al. 2007). It has also been reported that
Ag? ions uncouple the respiratory chain from oxidative
phosphorylation or collapse the proton-motive force across
the cytoplasmic membrane (Holt and Bard 2005). The
present study was made an attempt to find out the anti-
bacterial activity of silver nanoparticles against the 6 uri-
nary tract infectious (UTIs) bacterial isolates.
Materials and methods
Preparation of silver nanoparticles
The silver nanoparticles were prepared by using chemical
reduction method (Fang et al. 2005). 50 ml of 1 9 10-3 M
AgNO3 was heated to boiling and 5 ml of 1% tri-sodium
citrate was added drop by drop. The solution was mixed
vigorously and heated until colour change was evident
(pale brown) and stirred until cooled to room temperature.
All solutions of reacting materials were prepared in double
distilled water. The aqueous solution was air dried up to
3 days so as to enable to obtain powdered form of sliver
nanoparticles.
Characterization of synthesized silver nanoparticles
About 1 ml of solution (diluted with 1:20 v/v Milli Q
water) was monitored in UV–VIS spectrophotometer
(between 300- and 700-nm ranges with 5-nm intervals)
with different time intervals (15 min, 30 min, 4 h, 6 h and
8 h). After 8 h of incubation, the solution was centrifuged
with 12,000 rpm for 20 min and their pellets were re-dis-
persed in sterile distilled water. The centrifugation and
re-dispersion was repeated three times to ensure the com-
plete separation of nanoparticles. The dried mixture of
silver nanoparticles was further analysed with X-ray dif-
fractometer (PAN analytical BV, The Netherlands) oper-
ated at a voltage of 40 kV and a current of 30 mA with Cu
Ka radiation in a h–2h configuration.
Isolation of UTI bacterial pathogens
A total of 50 urine samples from 25 male and 25 female
patients admitted in the hospitals as UTI problems were
collected from different hospitals and laboratory localities
along the coastal area of Thondi, Ramanathapuram Dis-
trict, Tamil Nadu, India in a separate sterile wide mouth
bottle. Before collecting a sample, the women were
instructed to swab the vulvae and men to retract the fore-
skin and cleanse the glans penis. Mid stream urine was
collected in a sterile wide mouthed container. For the
isolation of UTI bacterial strains, loop full of urine samples
were streaked into the nutrient agar, MacConkey agar,
Blood agar and Chocolate agar plates and incubated at
37 ± 2C for 24 h. Next day individual colonies were
selected and identified on the basis of morphological
characteristics, gram staining, and biochemical characters
(Thomas 1995; Chess Brough 2000).
Antibacterial sensitivity assay
Disc diffusion assay was performed to determine the
antibacterial activity in triplicates (Kim et al. 1995).
Overnight culture of UTI pathogens were swabbed over
the surface of sterile Mueller–Hinton agar plates using
sterile cotton swabs. Discs impregnated with different
concentrations of silver nanoparticles (5, 10, 15 and
20 lg disc-1) were applied on the solid agar medium by
pressing slightly and incubated at 37 ± 2C for 24 h in
triplicates. After incubation, the zone of inhibition was
measured and expressed as zone of sensitivity millimetre
in diameter.
Results
Out of the 50 midstream urine samples, 32 bacterial iso-
lates were recovered and the biochemical tests revealed
that, these isolates belong to 6 species (Table 1). Of these
E. coli is the predominant one (47%); Pseudomonas
aeruginosa (22%), K. pneumonia (19%), Enterobacter sp.
(6%), Proteus morganii (3%) and Staphylococcus aureus
(3%) (Fig. 1). The colour intensity of the synthesized silver
nanoparticles was increased with increased time duration,
and the maximum intensity was observed with 420-nm
wavelength (Fig. 2). Further, the results of the X-ray dif-
fraction (XRD) analysis showed 2h intense values with
various degrees (36.20, 54.56, 63.11 and 68.72) and
these results correspond to (111), (200), (220) and (311)
Bragg’s reflection-based (Sathishkumar et al. 2009) silver
nanoparticles (Fig. 3). Antibacterial activity of silver
nanoparticles is represented in Table 2. The silver nano-
particles showed maximum sensitivity (11 ± 0.58 mm)
against P. aeruginosa followed by Enterobacter sp. (8 ±
0.49 mm) at 20 lg disc-1 concentration. The P. aerugin-
osa and Enterobacter sp. showed sensitivity against all
the tested concentrations (5, 10, 15 and 20 lg disc-1).
K. pneumoniae, E. coli, P. morganii and S. aureus showed
no sensitivity against all the tested concentrations of silver
nanoparticles.
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Discussion
Patients with non-infectious disease who have stay in
hospital have high risk to acquire nosocomial infection. It
has been reported that, 10% hospital patients acquire this
infection while staying in hospital (Asefzadeh 2005).
Martinez and Baquero (2002) have reported from their
research that, nosocomial infectious bacteria exhibited
least susceptibility to antibiotics and some of these bacteria
out rightly developed multidrug resistance to these antibi-
otics. Recently from a 3-year follow-up study in USA,
Dowzicky and Park (2008) reported that, UTI bacterial













Gram staining - - - - - ?
TSI
Slant K A A A K A
Butt K A A A A A
GAS - G G G G -
H2S - - - - - -
Mannitol A A A A - -
Motility Motile Motile Non-motile Motile Motile Motile
Indole test - - - - ? -
Methyl red test ? ? - - ? -
V.P. test - - ? ? - -
Citrate test - - ? - - -
Urease test ? - ? - ? -
Oxidase test ? - - - - -
Catalase test ? - - - ? ?
? Positive, - negative, K alkaline, A acid, G gas
Fig. 1 Percentage occurrence and distribution of bacterial pathogens
in UTIs among the patients (n = 32)
Fig. 2 UV–VIS absorption spectra of the synthesized silver
nanoparticles
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Fig. 3 XRD analysis of the synthesized silver nanoparticles
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pathogens have exhibited decreased susceptibility rates to
tigecycline over the years. Antibacterial property of silver
nanoparticles would be the alternative to overcome the
resistance problem.
In our present study, E. coli (47%) was found predom-
inant and a similar result was reported by Ravikumar et al.
(2010). Despite the availability of antibiotics, UTIs remain
the most common bacterial infections in human popula-
tions (Phillippon et al. 1989). Urinary tract infections occur
more frequently in females (63%) than in males (Schaeffer
et al. 2001). Silver is known for its antimicrobial properties
and has been used for years in the medical field for anti-
microbial applications and even has shown to prevent HIV
binding to host cells (Nino-Martinez et al. 2008; Alt et al.
2004; Lee et al. 2007). Additionally, silver has been used in
water and air filtration to eliminate microorganisms (Chou
et al. 2005).
Previous reports stated that, the silver nanoparticles
have potential antibacterial property against E. coli,
S. aureus, Staphylococcus epidermis, Leuconostoc mesen-
teroides, Bacillus subtilis, Klebsiella mobilis and
K. pneumonia (Benn and Westerhoff 2008; Chen and
Chiang 2008; Falletta et al. 2008; Hernandez-Sierra et al.
2008; Ingle et al. 2008; Jung et al. 2009; Kim 2007; Kim
et al. 2007, 2009; Kvitek et al. 2008; Raffi et al. 2008;
Ruparelia et al. 2008; Smetana et al. 2008; Sondi and Sa-
lopek-Sondi 2004; Vertelov et al. 2008; Yang et al. 2009;
Yoon et al. 2008a, b). It has been shown that silver nano-
particles prepared with a variety of synthetic methods have
effective antimicrobial activity (Lok et al. 2006; Baker
et al. 2005; Aymonier et al. 2002; Melaiye et al. 2005;
Sondi and Salopek-Sondi 2004; Kim et al. 2008; Lee et al.
2008; Alt et al. 2004). In the present study, the silver
nanoparticles were prepared by chemical reduction method
to assess the antibacterial activity. The results of the UV–
VIS absorption showed increasing colour intensity with
increased time intervals and this might be due to the pro-
duction of the silver nanoparticles and the formation of the
brownish yellow colour might be due to the excitation of
the surface plasmon vibration of the synthesized silver
nanoparticles (Krishnaraj et al. 2010). The result of the
XRD pattern indicates the presence of sharp bands of
Bragg peaks and this might be due to the stabilizing of the
synthesized nanoparticles by chemical reducing agents and
thus confirming the crystallization of the bioorganic phase
occurs on the surface of the silver nanoparticles (Sat-
hishkumar et al. 2009).
Pseudomonas aeruginosa showed maximum sensitivity
(11 ± 0.58 mm) at 20 lg disc-1 followed by Enterobacter
sp. (8 ± 0.49 mm). The predominant isolate E. coli
showed no sensitivity, it might be due to the multidrug
resistance nature of E. coli developed by point mutations.
The mechanism of action may be due to the silver and
silver nanoparticles attach to the surface of the cell mem-
brane and disturbing permeability and respiration functions
of the cell, moreover, due to the uptake of free silver ions
followed by disruption of ATP production and DNA rep-
lication. Smaller silver and silver nanoparticles having the
large surface area available for interaction would give more
bactericidal effect than the larger silver and silver nano-
particles (Kvitek et al. 2008). Normally silver nanoparticles
interactions with bacteria are dependent on the size and
shape of the nanoparticles (Panacek et al. 2006; Morones
et al. 2005; Pal et al. 2007). It is concluded from the present
study that, the silver nanoparticles could be used as an
effective antibacterial agent for the management of urinary
tract infections caused by P. aeruginosa and Enterobacter
sp. after successful completion of in vivo studies and
clinical trials.
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Table 2 Antimicrobial activity of silver nanoparticles against UTIs pathogens
Test organism Zone of inhibition (mm)
Concentration of silver nanoparticles (lg disc-1) Positive control (20 lg disc-1) Negative control
5 10 15 20 Kanamycin Tetracycline Sterile distilled water
Pseudomonas aeruginosa (n = 15) 7.0 ± 0.49 8.0 ± 0.61 9.0 ± 0.65 11 ± 0.58 9 ± 0.69 7 ± 0.75 -
Enterobacter sp. (n = 7) 6.0 ± 0.37 6.0 ± 0.52 7.0 ± 0.58 8 ± 0.49 - 8 ± 0.62 -
Klebsiella pneumoniae (n = 6) - - - - - - -
Escherichia coli (n = 2) - - - - - - -
Proteus morganii (n = 1) - - - - - 7 ± 0.54 -
Staphylococcus aureus (n = 1) - - - - - - -
n Number of isolates, - no sensitivity, ± standard deviation
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